Showing results (61-70 of 124) with videos related to
Sort By:
Pageof 13
International Journal of Molecular Sciences|December 8, 2017
CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma PatientsThomas Greither, Alice Wedler, Swetlana Rot, et al.Pediatric Pulmonology|October 14, 2021
Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Whole lung lavages for long-term bridging to hematopoietic stem cell transplantationElias Seidl, Dirk Schramm, Carola Schön, et al.BMC Cancer|July 4, 2012
Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patientsThomas Greither, Franziska Koser, Matthias Kappler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survivalMatthias Kappler, Matthias Kotzsch, Frank Bartel, et al.Oncogene|April 28, 2005
Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patientsHelge Taubert, Matthias Kappler, Matthias Bache, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung diseaseBarbara Koller, Matthias Kappler, Phillip Latzin, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 10, 2014
Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patientsHenri Wichmann, Antje Güttler, Matthias Bache, et al.BMC Cancer|April 10, 2010
Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patientsMatthias Bache, Matthias Kappler, Henri Wichmann, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 16, 2010
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trialMichael W Konstan, Patrick A Flume, Matthias Kappler, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 9, 2014
Predictive values of antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis one year after early eradication treatmentMatthias Kappler, Felicitas Nagel, Maria Feilcke, et al.Pageof 13